Given the high unmet need for drug-linked PML risk prediction and preliminary data that PML patients have an underlying immunodeficiency disorder, we sought to identify germline variants in PML cases for development of a PML genetic risk test. This evidence concerns the gene PML and immunodeficiency disease.